Medtronic has recalled more than 204,000 devices used to assist hospital and other patients with end-stage heart failure due to the potential for power source interruptions, the Food and Drug Administration reported Friday. The HeartWare Ventricular Assist Device is used as a bridge to cardiac transplantation in patients who are at risk of death from end-stage left ventricular heart failure. Health care professionals and consumers may report adverse reactions and quality problems with the devices to the FDA’s MedWatch program. For more information, see the recent Medtronic letter to health care providers.

Related News Articles

Headline
Hartford HealthCare in Hartford, Conn., will receive the 2025 AHA Quest for Quality Prize as a result of their sweeping transformation over the past decade —…
Headline
A Q&A in the July edition of AHA Trustee Insights features leaders from Winchester Hospital in Massachusetts discussing the importance of board members…
Headline
To help hospitals across the country improve sepsis care, the Centers for Disease Control and Prevention created the Hospital Sepsis Program Core Elements,…
Headline
The Joint Commission June 30 announced a new, streamlined process that removes 714 requirements from its hospital accreditation program. The new program,…
Headline
AHA President and CEO Rick Pollack explains how hospitals have made meaningful progress in patient safety and delivering high-quality care, in a column…
Headline
A 60-day appeal window has passed for the Food and Drug Administration to appeal a federal court ruling that invalidated its final rule to regulate laboratory-…